[1] 王瑞,李玲,刘正敏,等.基于HIV检测结果对反应性献血者分类管理的探讨[J].中国输血杂志,2022,35(3):296-300. [2] 王宇骁,王涛,王宇航.《献血者健康检查要求》(GB18467-2011)在日常工作中的心得体会[J].中国输血杂志,2012,25(S1):31. [3] PILLONEL J,PELAT C,TIBERGHIEN P,et al.The evolving blood donor deferral policy for men who have sex with men:impact on the risk of HIV transmission by transfusion in France[J].Transfusion,2020,60(3):525-534. [4] MAPAKO T,MVERE D A,CHITIYO M E,et al.Human immunodeficiency virus prevalence,incidence,and residual transmission risk in first-time and repeat blood donations in Zimbabwe:implications on blood safety[J].Transfusion,2013,53(10pt2):2413-2421. [5] 葛文超,吕永磊,陈明军,等.郑州地区无偿献血者血液筛查中丙型肝炎病毒残余风险的评估[J].中国输血杂志,2022,35(5):546-549. [6] 董杰,祝宏,凌霞,等.杭州地区无偿献血者血液筛查中丙型肝炎病毒残余风险的评估[J].中国现代医生,2020,58(16):144-147. [7] WANG J X,LIU J,YAO F Z,et al.Prevalence,incidence,a nd residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors[J].Transfusion,2013,53(6):1240-1249. [8] BRUHN R,LELIE N,CUSTER B,et al.Prevalence of human immunodeficiency virus RNA and antibody in first-time,lapsed,and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios[J].Transfusion,2013,53(10pt2):2399-2412. [9] 冯惟萍,张支凤,吴康乐,等.兰州地区输血传播HIV残余风险规避策略研究[J].中国艾滋病性病,2022,28(2):199-202. [10] 陕柏峰,史宏睿,焦东丽.太原市血液筛查后输血传播HIV残余风险度的评估[J].中国艾滋病性病,2020,26(5):540-542. [11] 何子毅,陈庆恺,陈少彬,等.四种血液安全筛查模式对经血传播病毒残余风险的评估[J].中国输血杂志,2018,31(2):140-143. [12] 张品品,李江,何刚,等.自贡地区无偿献血人群HIV感染情况及人群特征分析[J].中国输血杂志,2018,31(11):1288-1291. [13] 吴洁,潘安杰,张艳,等.芜湖地区无偿献血者HIV筛查策略及确认结果分析[J].中国输血杂志,2021,34(3):293-296. [14] GREBE E,BUSCH M P,NOTARI E P,et al.HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men[J].Blood,2020,136(11):1359-1367. [15] VERMEULEN M,LELIE N,COLEMAN C,et al.Assessment of HIV transfusion transmission risk in South Africa:a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes[J].Transfusion,2019,59(1):267-276. [16] 冯娟. 安阳地区无偿献血人群HIV输血风险评估[J].中国输血杂志,2016,29(2):171-173. [17] 段学云,左江涛,焦东丽,等.太原市无偿献血者HIV流行率及血液筛查后残余风险度的评估[J].中国卫生检验杂志,2015,25(3):417-419. [18] GRUBYTĖ S,URBONIENĖ J,NEDZINSKIENE L,et al.Prevalence,incidence and residual risk of transfusion transmitted viruses (HBV,HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018:the incidence/window-period model study[J].PLoS One,2021,16(2):e246704. [19] 谢君谋,廖芬芳,王淏,等.2例重复献血者HIV血清学检测窗口期追踪结果分析[J].临床输血与检验,2022,24(5):647-650. [20] 王静,文赟筠,周春,等.南京市无偿献血者HIV感染状况及防控策略分析[J].临床输血与检验,2018,20(5):485-488. [21] 张荣秋,张建梅,李莉.HIV-1抗体不确定患者追踪随访及其病毒载量分析[J].中国艾滋病性病,2020,26(6):584-586. [22] 樊璐. 2012-2019年南昌地区无偿献血者HIV初筛和确证结果分析[J].中国艾滋病性病,2020,26(12):1286-1289. [23] 李浩,朱阳泉,苗琦.镇江市无偿献血者HIV检测结果回顾性分析[J].实验与检验医学,2021,39(1):233-235. [24] 戚晓东,臧传邦,宋雪梅.血站酶联免疫检测联合核酸检测降低输血传播疾病残余风险的效果分析[J].中国卫生检验杂志,2016,26(3):373-374. |